Busulfan in children: impact of development on dose-exposure-response relationship?
Dalal
Jignesh
J
Children's Mercy Hospital, Pediatric Hematology/Oncology, Kansas City, Missouri 64108, USA. jddalal@cmh.edu
Neville
Kathleen A
KA
D000293:Adolescent; D002066:Busulfan / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D019653:Myeloablative Agonists / Q000008:administration & dosage* / Q000493:pharmacokinetics*
D019653:Myeloablative Agonists; D002066:Busulfan